Background: Acne Vulgaris is a complex illness linked to the pilosebaceous unit. Almost 85% of adolescents suffer from this disease, which results in a higher incidence of low self-esteem since it affects primarily the face. Inflammatory and non-inflammatory lesions are common in acne vulgaris. There are different lines of treatment that can be tailored to the patient's condition. New modalities emerge every day to combat the possible side effects of the traditional lines.
Objective: To determine the updated treatment modalities in acne vulgaris management.
Conclusion: Several modalities have been introduced to treat acne vulgaris including topical, systemic, light assisted, and novel topical agents like Triafortene and Nitric oxide gels.